Boltz PBC Uses Excelra's GOSTAR Data to Enhance AI Drug Discovery Models
Boltz PBC has partnered with Excelra to enhance its AI-driven drug discovery models using curated ADMET data from Excelra's GOSTAR database. The GOSTAR-trained models in BoltzMol-1 efficiently filter out unfavorable compounds early, demonstrating success by confirming active compounds for six out of ten challenging targets with significantly fewer compounds than traditional methods. Both companies highlight the dataset's scale and quality as key to improving model generalization and accelerating drug discovery processes.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 37/100.
Outlets measured: thetribune, thehindu. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thehindu broke this story on 10 Nov, 08:00 pm. Other outlets followed.
- 1